Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.63 |
| ▸ | ATM | Q13315 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.47 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Clibucaine SCHEMBL32668857 | 1.00 | ALDH1A1 (0.63) | ALDH1A1ATMMAPTPOLBSMN1; SMN2 | |
| Clibucaine SCHEMBL1815025 | 0.79 | HRH3 (0.58) | ALDH1A1ATMMAPTPOLBSMN1; SMN2 | |
| SCHEMBL30023041 | 0.73 | HPGD (0.59) | ALDH1A1ATMMAPTPOLBSMN1; SMN2 | |
| SCHEMBL497131 | 0.73 | POLB (0.72) | ALDH1A1ATMMAPTPOLBSMN1; SMN2 | |
| SCHEMBL9631346 | 0.72 | ALDH1A1 (0.54) | ALDH1A1MAPTPOLBSMN1; SMN2TDP1 | |
| SCHEMBL11578349 | 0.72 | HPGD (0.65) | ALDH1A1ATMMAPTPOLBSMN1; SMN2 | |
| SCHEMBL29387484 | 0.72 | ALDH1A1 (0.76) | ALDH1A1MAPTPOLBSMN1; SMN2TDP1 | |
| SCHEMBL4593633 | 0.71 | MAPT (0.77) | ALDH1A1ATMMAPTPOLBHTT | |
| SCHEMBL9180503 | 0.70 | HPGD (0.68) | ALDH1A1ATMMAPTPOLBSMN1; SMN2 | |
| SCHEMBL31590796 | 0.70 | HPGD (0.68) | ALDH1A1ATMMAPTPOLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4436552-B1 | GASTRO-RETENTIVE ORAL DOSAGE UNIT CONTAINING A LOCAL ANAESTHETIC | OREXA B V (NL) | 2026-02-04 | — | — | EP | claimed |
| EP-4578441-A1 | TREATMENT OF LOCALIZED PAIN | PlantTec Medical GmbH (DE) | 2025-07-02 | — | — | EP | claimed |
| WO-2025043048-A1 | METHODS AND SYSTEMS FOR DELIVERY OF MODIFIED AGAROSE POLYSACCHARIDES | RELIVE THERAPEUTICS INC. (US) | 2025-02-27 | — | — | WO | claimed |
| US-20250009689-A1 | GASTRO-RETENTIVE ORAL DOSAGE UNIT CONTAINING A LOCAL ANAESTHETIC | OREXA B.V. (NL) | 2025-01-09 | — | — | US | claimed |
| EP-4436552-A1 | GASTRO-RETENTIVE ORAL DOSAGE UNIT CONTAINING A LOCAL ANAESTHETIC | Orexa B.V. (NL) | 2024-10-02 | — | — | EP | claimed |
| WO-2023094100-A1 | GASTRO-RETENTIVE ORAL DOSAGE UNIT CONTAINING A LOCAL ANAESTHETIC | OREXA B.V. (NL) | 2023-06-01 | — | — | WO | claimed |
| EP-4051167-A1 | READY-TO-USE ESTHETIC COMPOSITIONS | Galderma Holding SA (CH) | 2022-09-07 | — | — | EP | claimed |
| US-20220133951-A1 | READY-TO-USE ESTHETIC COMPOSITIONS | Galderma Holding SA (CH) | 2022-05-05 | — | — | US | claimed |
| US-11235087-B2 | Ready-to-use esthetic compositions | Galderma Holding SA (CH) | 2022-02-01 | — | — | US | claimed |
| WO-2021084421-A1 | READY-TO-USE ESTHETIC COMPOSITIONS | Galderma Holding SA (CH) | 2021-05-06 | — | — | WO | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| WO-2007041476-A2 | INDICATIONS FOR LOCAL TRANSPORT OF ANAESTHETIC AGENTS BY ELECTROTRANSPORT DEVICES | VYTERIS, INC. (US) | 2007-04-12 | — | — | WO | claimed |
| US-20070078434-A1 | Indications For Local Transport of Anaesthetic Agents By Electrotransport Devices | VYTERIS, INC. (US) | 2007-04-05 | — | — | US | claimed |
| EP-1586347-A1 | Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability | Vyteris, Inc. (US) | 2005-10-19 | — | — | EP | claimed |
| US-20050228336-A1 | Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability | COLLATERAL AGENTS, LLC | 2005-10-13 | — | — | US | claimed |
| US-6929805-B2 | For oral administration comprising an analgesic with rapid onset of action and at least one systemically acting analgesic with sustained action, such as a combination of benzocaine and acetylsalicylic acid (ASA) | BAYER AKTIENGESELLSCHAFT (DE) | 2005-08-16 | — | — | US | claimed |
| US-6071959-A | FOR RELIEVING PAIN OF LOWER GASTROINTESTINAL TRACT BY RECTAL OR ORAL ADMINISTRATION OF A COMPLEX OF AMIDE-TYPE LOCAL ANAESTHETIC AND POLYACRYLATE WITH CARRIER, DILUENT AND/OR EXCIPIENT | RHODES JOHN (GB) | 2000-06-06 | — | — | US | claimed |
| EP-0914106-A1 | PHARMACEUTICAL PRODUCTS CONTAINING A COMPLEX OF AN AMIDE-TYPE LOCAL ANESTHETIC AND A POLYACRYLATE | RHODES, John (GB) | 1999-05-12 | — | — | EP | claimed |
| WO-1997044021-A1 | PHARMACEUTICAL PRODUCTS CONTAINING A COMPLEX OF AN AMIDE-TYPE LOCAL ANESTHETIC AND A POLYACRYLATE | RHODES JOHN (GB) | 1997-11-27 | — | — | WO | claimed |